ZSTK-474

Term ID

CHEBI:90545

Synonyms

1-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole
2-(2-difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole
4,4'-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
ZSTK 474
ZSTK474

Definition

A triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: benzimidazoles morpholines organofluorine compound triamino-1,3,5-triazine

benzimidazoles morpholines organofluorine compound triamino-1,3,5-triazine Show first 5 Terms
has_role: antineoplastic agent EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor

antineoplastic agent EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor Show first 5 Terms

Phenotype

Phenotype resulting from ZSTK-474

Phenotype where environments contain ZSTK-474

Phenotype modified by environments containing ZSTK-474

Human Disease Model